Distinct antibody repertoires against endemic human coronaviruses in children and adults.
Adult
Antibodies, Viral
/ blood
Antibody Specificity
Antigens, Viral
/ blood
Child
Child, Preschool
Common Cold
/ blood
Coronavirus
/ immunology
Coronavirus Infections
/ blood
Cross Reactions
Endemic Diseases
Epitopes, B-Lymphocyte
/ blood
Female
Humans
Male
Middle Aged
Protein Domains
/ immunology
Retrospective Studies
Seroepidemiologic Studies
Viral Proteins
/ immunology
Immunoglobulins
Immunology
Infectious disease
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
22 02 2021
22 02 2021
Historique:
received:
21
09
2020
accepted:
13
01
2021
pubmed:
27
1
2021
medline:
9
3
2021
entrez:
26
1
2021
Statut:
epublish
Résumé
Four endemic human coronaviruses (HCoVs) are commonly associated with acute respiratory infection in humans. B cell responses to these "common cold" viruses remain incompletely understood. Here we report a comprehensive analysis of CoV-specific antibody repertoires in 231 children and 1168 adults using phage immunoprecipitation sequencing. Seroprevalence of antibodies against endemic HCoVs ranged between approximately 4% and 27% depending on the species and cohort. We identified at least 136 novel linear B cell epitopes. Antibody repertoires against endemic HCoVs were qualitatively different between children and adults in that anti-HCoV IgG specificities more frequently found among children targeted functionally important and structurally conserved regions of the spike, nucleocapsid, and matrix proteins. Moreover, antibody specificities targeting the highly conserved fusion peptide region and S2' cleavage site of the spike protein were broadly cross-reactive with peptides of epidemic human and nonhuman coronaviruses. In contrast, an acidic tandem repeat in the N-terminal region of the Nsp3 subdomain of the HCoV-HKU1 polyprotein was the predominant target of antibody responses in adult donors. Our findings shed light on the dominant species-specific and pan-CoV target sites of human antibody responses to coronavirus infection, thereby providing important insights for the development of prophylactic or therapeutic monoclonal antibodies and vaccine design.
Identifiants
pubmed: 33497357
pii: 144499
doi: 10.1172/jci.insight.144499
pmc: PMC7934927
doi:
pii:
Substances chimiques
Antibodies, Viral
0
Antigens, Viral
0
Epitopes, B-Lymphocyte
0
Viral Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Virology. 2006 Jul 5;350(2):358-69
pubmed: 16519916
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Viruses. 2014 Aug 07;6(8):2991-3018
pubmed: 25105276
Pediatr Infect Dis J. 2011 Apr;30(4):279-83
pubmed: 21057374
Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2
pubmed: 32183941
Annu Rev Microbiol. 2019 Sep 8;73:529-557
pubmed: 31226023
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
BMC Public Health. 2015 Dec 03;15:1208
pubmed: 26635005
Crit Care. 2020 May 6;24(1):198
pubmed: 32375845
Infect Genet Evol. 2008 Jul;8(4):397-405
pubmed: 17881296
J Clin Virol. 2009 May;45(1):54-60
pubmed: 19342289
J Clin Invest. 2020 Jun 1;130(6):2757-2765
pubmed: 32254064
Nat Protoc. 2019 Aug;14(8):2596
pubmed: 30361618
Can J Microbiol. 2009 Mar;55(3):254-60
pubmed: 19370068
Immunotherapy. 2020 Jun;12(8):571-576
pubmed: 32397847
Science. 2015 Jun 5;348(6239):aaa0698
pubmed: 26045439
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
J Infect Dis. 1974 Mar;129(3):271-6
pubmed: 4816305
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
Nat Med. 2019 Apr;25(4):591-596
pubmed: 30886409
Nat Immunol. 2021 Jan;22(1):25-31
pubmed: 33154590
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Adv Virus Res. 2018;100:163-188
pubmed: 29551135
J Clin Microbiol. 2010 Aug;48(8):2940-7
pubmed: 20554810
Proc Natl Acad Sci U S A. 1967 Apr;57(4):933-40
pubmed: 5231356
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Nat Struct Mol Biol. 2019 Jun;26(6):481-489
pubmed: 31160783
Viruses. 2012 Jun;4(6):1011-33
pubmed: 22816037
N Engl J Med. 2003 May 15;348(20):1967-76
pubmed: 12690091
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
NPJ Vaccines. 2019 Sep 6;4:38
pubmed: 31508246
Science. 2020 Jun 26;368(6498):1481-1486
pubmed: 32350060
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7988-93
pubmed: 15897467
J Virol. 2015 Nov;89(21):10786-801
pubmed: 26269191
J Infect Dis. 2020 Nov 13;222(12):1974-1984
pubmed: 32910175
Curr Protoc Bioinformatics. 2019 Jun;66(1):e74
pubmed: 31039604
Curr Top Microbiol Immunol. 2005;287:57-94
pubmed: 15609509
Int J Biol Sci. 2020 Mar 15;16(10):1718-1723
pubmed: 32226289
J Gen Virol. 2020 Aug;101(8):791-797
pubmed: 32430094
World J Clin Pediatr. 2016 Nov 8;5(4):391-396
pubmed: 27872828
Emerg Microbes Infect. 2020 Dec;9(1):833-836
pubmed: 32306864
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2681-2690
pubmed: 30679277
J Virol. 2006 Jul;80(14):7270-4
pubmed: 16809333
Front Microbiol. 2018 Dec 05;9:2991
pubmed: 30568643
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Immunity. 2010 Oct 29;33(4):451-63
pubmed: 21029957
Adv Virus Res. 2019;105:93-116
pubmed: 31522710
J Clin Invest. 2020 Apr 1;130(4):1545-1548
pubmed: 32167489
J Mol Biol. 2017 Dec 8;429(24):3875-3892
pubmed: 29056462
Cell. 2018 Mar 8;172(6):1319-1334
pubmed: 29522750
N Engl J Med. 2020 Jan 30;382(5):437-445
pubmed: 31995689
J Clin Microbiol. 2008 Jul;46(7):2368-73
pubmed: 18495857
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
Pediatr Infect Dis J. 2020 May;39(5):355-368
pubmed: 32310621
JAMA. 2020 Apr 21;323(15):1488-1494
pubmed: 32125362
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
Nat Med. 2004 Apr;10(4):368-73
pubmed: 15034574
J Virol. 2005 Jan;79(2):884-95
pubmed: 15613317
Sci Transl Med. 2015 Dec 2;7(316):316ra192
pubmed: 26631631
J Clin Virol. 2012 Feb;53(2):135-9
pubmed: 22188723
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Proc Soc Exp Biol Med. 1966 Jan;121(1):190-3
pubmed: 4285768
Science. 2019 Nov 1;366(6465):599-606
pubmed: 31672891
Am J Epidemiol. 1972 Aug;96(2):94-106
pubmed: 4626012
J Clin Virol. 2007 Nov;40(3):207-13
pubmed: 17889596
Nat Commun. 2020 Jun 1;11(1):2806
pubmed: 32483236
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Nucleic Acids Res. 2019 Jul 2;47(W1):W502-W506
pubmed: 31114900
Front Immunol. 2019 Mar 22;10:548
pubmed: 30967872
Cell. 2019 Feb 21;176(5):1026-1039.e15
pubmed: 30712865